multiple sclerosis

(redirected from relapsing-remitting multiple sclerosis)
Also found in: Thesaurus, Medical, Encyclopedia.

multiple sclerosis

n. Abbr. MS
A chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord or both, interfering with the nerve pathways and causing muscular weakness, loss of coordination, and speech and visual disturbances.

multiple sclerosis

n
(Pathology) a chronic progressive disease of the central nervous system characterized by loss of some of the myelin sheath surrounding certain nerve fibres and resulting in speech and visual disorders, tremor, muscular incoordination, partial paralysis, etc. Also called: disseminated sclerosis Abbreviation: MS

mul′tiple sclero′sis


n.
a chronic degenerative disease marked by patchy destruction of the myelin that surrounds and insulates nerve fibers and mild to severe neural and muscular impairments.
[1880–85]

multiple scle·ro·sis

(sklə-rō′sĭs)
A disease of unknown cause in which the sheaths around nerve fibers become damaged. The nerves in the brain, spinal cord, and eye are most commonly affected, causing weakness, loss of balance and coordination, and visual disturbances.

multiple sclerosis

(MS) A disease that is thought to be caused by an autoimmune disorder. It attacks the protective coverings of nerve fibers in the brain and spinal cord. Symptoms vary in severity but can include paralysis.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.multiple sclerosis - a chronic progressive nervous disorder involving loss of myelin sheath around certain nerve fibers
degenerative disorder - condition leading to progressive loss of function
demyelination - loss of the myelin covering of some nerve fibers resulting in their impaired function
induration, sclerosis - any pathological hardening or thickening of tissue
autoimmune disease, autoimmune disorder - any of a large group of diseases characterized by abnormal functioning of the immune system that causes your immune system to produce antibodies against your own tissues
Translations
roztroušená skleróza
dissemineret sklerose
multippeli skleroosi
multipla skleroza
多発性硬化症
다발성 경화증
multipel skleros
โรคปลอกหุ้มเส้นประสาทอักเสบ
bệnh đa xơ cứng

multiple sclerosis

nsclerosi f a placche

multiple sclerosis

التَصَلُّبُ اللويحي الـمُتَعَدِّدَة roztroušená skleróza dissemineret sklerose Multiple Sklerose σκλήρυνση κατά πλάκας esclerosis múltiple multippeli skleroosi sclérose en plaques multipla skleroza sclerosi multipla 多発性硬化症 다발성 경화증 multiple sclerose multippel sklerose stwardnienie rozsiane esclerose múltipla рассеянный склероз multipel skleros โรคปลอกหุ้มเส้นประสาทอักเสบ multipl skleroz bệnh đa xơ cứng 多发性硬化

mul·ti·ple scle·ro·sis

n. esclerosis múltiple, enfermedad progresiva lenta del sistema nervioso central causada por pérdida de la capa de mielina que cubre las fibras nerviosas del cerebro y de la médula espinal.
References in periodicals archive ?
In the next step, the researchers analysed the substance in mice suffering from a disease comparable with relapsing-remitting multiple sclerosis in humans.
M2 EQUITYBITES-December 4, 2017-Merck passes Health Canada's approval for MAVENCLAD (Cladribine Tablets) to treat relapsing-remitting multiple sclerosis
M2 PHARMA-December 4, 2017-Merck passes Health Canada's approval for MAVENCLAD (Cladribine Tablets) to treat relapsing-remitting multiple sclerosis
in patients with relapsing-remitting multiple sclerosis in Japan as well as data from overseas clinical trials conducted by Teva.
Plegridy (peginterferon beta-1a, manufactured by Biogen Idec) is the newest disease-modifying therapy, or DMT, to be approved by the Food & Drug Administration for relapsing-remitting multiple sclerosis.
SAN DIEGO--Full results of the second phase III trial of dimethyl fumarate in relapsing-remitting multiple sclerosis show that the investigational drug reduces annualized relapse rates and MRI lesions over the course of 2 years.
SAN DIEGO -- Full results of the second phase III trial of dimethyl fumarate in patients with relapsing-remitting multiple sclerosis show that the investigational drug significantly reduced annualized relapse rates and MRI lesions over the course of 2 years.
Fingolimod can help reduce relapses in adults with highly active relapsing-remitting multiple sclerosis (RRMS).
Yesterday, Genmab announced encouraging interim results from a phase II clinical trial with its product ofatumumab in relapsing-remitting multiple sclerosis (RRMS).
The results "provide a new horizon for patients with relapsing-remitting multiple sclerosis and a welcome increase in the range of treatment options," neurologist William Carroll wrote in an editorial accompanying the studies in the New England Journal of Medicine.
Young PJ, Lederer C, Eder K et al Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosis.
Summary: TEHRAN (FNA)- A new study for comparing the efficacy of 250 micro/g or 500 micro/g interferon beta-1b with Glatiramer acetate for treating relapsing-remitting multiple sclerosis showed that both doses had similar clinical effects to Glatiramer acetate.